Tomás Cobo (Cgcom) and Jesús Aguilar (Cgcof).
The approval of the Health Commission of the Congress of Deputies in medical use of cannabis for therapeutic purposes has put on the table the need to train the professionals of the National Health System (SNS) who will be responsible for prescribing and delivering new drugs. A scenario that doctors as pharmacists They are already considering the medium term if the Ministry of Health finally takes the final step.
The General Council of Official Colleges of Physicians (Cgcof) explained that it plans to strengthen the knowledge of doctors in this area, but not specifically, but as part of the plans they maintain for the incorporation of any new medicine. “Training can be pharmacological or technical, which It is essential is this process of continuous training of the doctor”explained to medical writing your president, Thomas Cob.
The majority opinion adopted by the parliamentary groups determined that they would basically be the medical specialists those who would be in charge in each case of prescribing medical cannabis and finally ruled out the request for training such as PNV or ERC to facilitate the dispensation also through the Primary care area.
Despite this new responsibility, the collegiate body differs from the approach of Congress since it only endorses the use of these drugs for child patients with continuing status epilepticus who do not respond to any other type of medication. While the parliamentary agreement has put up to five different hypotheses on the table.
Pharmaceutical training for medical cannabis
Another of the professional sectors that is already analyzing training is that of pharmacists who will be responsible for dispensing drugs. The General Council of Official Orders of Pharmacy (Cfcof) acknowledged working on “training action” for office professionals, but it still has no date to make it effective.
Sources from the collegiate body explained to this newspaper that the training formula for professionals will be marked by the “exemption conditions specified by the Spanish Medicines and Health Products Agency (Amps)”.
Congressional groups have granted a six-month grace period to the institution that leads Mary Jesus Lamas so that it facilitates that the recommendations have a “are within the regulations and are viable”. While he was mandated to validate the “availability” of extracts and standardized cannabis preparations on the national market.
According to parliamentarians, Aemps plays a “crucial role” for the development of the project and coordination with the Autonomous Communities “It should define mechanisms in accordance with current regulations through which prescription and dispensing are possible.” Until this phase is completed, pharmacists will not refine their training plan.
The plan for the incorporation of medical cannabis must in any case still receive the approval of the Ministry of Health. So far, the advice approved by Congress has received support from the groups that make up the government coalition (PSOE and United We Can). While they also aligned with them Citizens, PNV and PDeCAT.
Although it may contain statements, data, or notes from healthcare institutions or professionals, the information in Medical Writing is edited and prepared by journalists. We recommend that the reader consult a healthcare practitioner with any health-related questions.
#training #doctors #pharmacies #cannabis #continued #Aemps